Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Mouse Model
1.2.3 Rat Model
1.3 Market by Application
1.3.1 Global Patient-derived Xenograft (PDX) Models Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Preclinical Drug development
1.3.3 Biomarker Analysis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Patient-derived Xenograft (PDX) Models Market Perspective (2018-2033)
2.2 Patient-derived Xenograft (PDX) Models Growth Trends by Region
2.2.1 Global Patient-derived Xenograft (PDX) Models Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Patient-derived Xenograft (PDX) Models Historic Market Size by Region (2018-2023)
2.2.3 Patient-derived Xenograft (PDX) Models Forecasted Market Size by Region (2024-2033)
2.3 Patient-derived Xenograft (PDX) Models Market Dynamics
2.3.1 Patient-derived Xenograft (PDX) Models Industry Trends
2.3.2 Patient-derived Xenograft (PDX) Models Market Drivers
2.3.3 Patient-derived Xenograft (PDX) Models Market Challenges
2.3.4 Patient-derived Xenograft (PDX) Models Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Patient-derived Xenograft (PDX) Models Players by Revenue
3.1.1 Global Top Patient-derived Xenograft (PDX) Models Players by Revenue (2018-2023)
3.1.2 Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Players (2018-2023)
3.2 Global Patient-derived Xenograft (PDX) Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Patient-derived Xenograft (PDX) Models Revenue
3.4 Global Patient-derived Xenograft (PDX) Models Market Concentration Ratio
3.4.1 Global Patient-derived Xenograft (PDX) Models Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patient-derived Xenograft (PDX) Models Revenue in 2022
3.5 Patient-derived Xenograft (PDX) Models Key Players Head office and Area Served
3.6 Key Players Patient-derived Xenograft (PDX) Models Product Solution and Service
3.7 Date of Enter into Patient-derived Xenograft (PDX) Models Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Patient-derived Xenograft (PDX) Models Breakdown Data by Type
4.1 Global Patient-derived Xenograft (PDX) Models Historic Market Size by Type (2018-2023)
4.2 Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Type (2024-2033)
5 Patient-derived Xenograft (PDX) Models Breakdown Data by Application
5.1 Global Patient-derived Xenograft (PDX) Models Historic Market Size by Application (2018-2023)
5.2 Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Patient-derived Xenograft (PDX) Models Market Size (2018-2033)
6.2 North America Patient-derived Xenograft (PDX) Models Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Patient-derived Xenograft (PDX) Models Market Size by Country (2018-2023)
6.4 North America Patient-derived Xenograft (PDX) Models Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Patient-derived Xenograft (PDX) Models Market Size (2018-2033)
7.2 Europe Patient-derived Xenograft (PDX) Models Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Patient-derived Xenograft (PDX) Models Market Size by Country (2018-2023)
7.4 Europe Patient-derived Xenograft (PDX) Models Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size (2018-2033)
8.2 Asia-Pacific Patient-derived Xenograft (PDX) Models Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size by Region (2018-2023)
8.4 Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Patient-derived Xenograft (PDX) Models Market Size (2018-2033)
9.2 Latin America Patient-derived Xenograft (PDX) Models Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Patient-derived Xenograft (PDX) Models Market Size by Country (2018-2023)
9.4 Latin America Patient-derived Xenograft (PDX) Models Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size (2018-2033)
10.2 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country (2018-2023)
10.4 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Detail
11.1.2 Crown Bioscience Business Overview
11.1.3 Crown Bioscience Patient-derived Xenograft (PDX) Models Introduction
11.1.4 Crown Bioscience Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.1.5 Crown Bioscience Recent Development
11.2 Champions Oncology
11.2.1 Champions Oncology Company Detail
11.2.2 Champions Oncology Business Overview
11.2.3 Champions Oncology Patient-derived Xenograft (PDX) Models Introduction
11.2.4 Champions Oncology Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.2.5 Champions Oncology Recent Development
11.3 Wuxi Apptec
11.3.1 Wuxi Apptec Company Detail
11.3.2 Wuxi Apptec Business Overview
11.3.3 Wuxi Apptec Patient-derived Xenograft (PDX) Models Introduction
11.3.4 Wuxi Apptec Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.3.5 Wuxi Apptec Recent Development
11.4 The Jackson Laboratory
11.4.1 The Jackson Laboratory Company Detail
11.4.2 The Jackson Laboratory Business Overview
11.4.3 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Introduction
11.4.4 The Jackson Laboratory Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.4.5 The Jackson Laboratory Recent Development
11.5 EPO Berlin-Buch
11.5.1 EPO Berlin-Buch Company Detail
11.5.2 EPO Berlin-Buch Business Overview
11.5.3 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Introduction
11.5.4 EPO Berlin-Buch Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.5.5 EPO Berlin-Buch Recent Development
11.6 Oncodesign
11.6.1 Oncodesign Company Detail
11.6.2 Oncodesign Business Overview
11.6.3 Oncodesign Patient-derived Xenograft (PDX) Models Introduction
11.6.4 Oncodesign Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.6.5 Oncodesign Recent Development
11.7 Xentech
11.7.1 Xentech Company Detail
11.7.2 Xentech Business Overview
11.7.3 Xentech Patient-derived Xenograft (PDX) Models Introduction
11.7.4 Xentech Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.7.5 Xentech Recent Development
11.8 Envigo
11.8.1 Envigo Company Detail
11.8.2 Envigo Business Overview
11.8.3 Envigo Patient-derived Xenograft (PDX) Models Introduction
11.8.4 Envigo Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.8.5 Envigo Recent Development
11.9 Charles River Laboratories
11.9.1 Charles River Laboratories Company Detail
11.9.2 Charles River Laboratories Business Overview
11.9.3 Charles River Laboratories Patient-derived Xenograft (PDX) Models Introduction
11.9.4 Charles River Laboratories Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.9.5 Charles River Laboratories Recent Development
11.10 Pharmatest Services
11.10.1 Pharmatest Services Company Detail
11.10.2 Pharmatest Services Business Overview
11.10.3 Pharmatest Services Patient-derived Xenograft (PDX) Models Introduction
11.10.4 Pharmatest Services Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.10.5 Pharmatest Services Recent Development
11.11 Urosphere
11.11.1 Urosphere Company Detail
11.11.2 Urosphere Business Overview
11.11.3 Urosphere Patient-derived Xenograft (PDX) Models Introduction
11.11.4 Urosphere Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.11.5 Urosphere Recent Development
11.12 MEDICILON
11.12.1 MEDICILON Company Detail
11.12.2 MEDICILON Business Overview
11.12.3 MEDICILON Patient-derived Xenograft (PDX) Models Introduction
11.12.4 MEDICILON Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.12.5 MEDICILON Recent Development
11.13 Horizon Discovery
11.13.1 Horizon Discovery Company Detail
11.13.2 Horizon Discovery Business Overview
11.13.3 Horizon Discovery Patient-derived Xenograft (PDX) Models Introduction
11.13.4 Horizon Discovery Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.13.5 Horizon Discovery Recent Development
11.14 Shanghai Model Organisms Center
11.14.1 Shanghai Model Organisms Center Company Detail
11.14.2 Shanghai Model Organisms Center Business Overview
11.14.3 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Introduction
11.14.4 Shanghai Model Organisms Center Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.14.5 Shanghai Model Organisms Center Recent Development
11.15 GemPharmatech
11.15.1 GemPharmatech Company Detail
11.15.2 GemPharmatech Business Overview
11.15.3 GemPharmatech Patient-derived Xenograft (PDX) Models Introduction
11.15.4 GemPharmatech Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.15.5 GemPharmatech Recent Development
11.16 LIDE Biotech
11.16.1 LIDE Biotech Company Detail
11.16.2 LIDE Biotech Business Overview
11.16.3 LIDE Biotech Patient-derived Xenograft (PDX) Models Introduction
11.16.4 LIDE Biotech Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.16.5 LIDE Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Mouse Model
Table 3. Key Players of Rat Model
Table 4. Global Patient-derived Xenograft (PDX) Models Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Patient-derived Xenograft (PDX) Models Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Patient-derived Xenograft (PDX) Models Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Patient-derived Xenograft (PDX) Models Market Share by Region (2018-2023)
Table 8. Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Patient-derived Xenograft (PDX) Models Market Share by Region (2024-2033)
Table 10. Patient-derived Xenograft (PDX) Models Market Trends
Table 11. Patient-derived Xenograft (PDX) Models Market Drivers
Table 12. Patient-derived Xenograft (PDX) Models Market Challenges
Table 13. Patient-derived Xenograft (PDX) Models Market Restraints
Table 14. Global Patient-derived Xenograft (PDX) Models Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Patient-derived Xenograft (PDX) Models Market Share by Players (2018-2023)
Table 16. Global Top Patient-derived Xenograft (PDX) Models Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patient-derived Xenograft (PDX) Models as of 2022)
Table 17. Ranking of Global Top Patient-derived Xenograft (PDX) Models Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Patient-derived Xenograft (PDX) Models Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Patient-derived Xenograft (PDX) Models Product Solution and Service
Table 21. Date of Enter into Patient-derived Xenograft (PDX) Models Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Patient-derived Xenograft (PDX) Models Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2018-2023)
Table 25. Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2024-2033)
Table 27. Global Patient-derived Xenograft (PDX) Models Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2018-2023)
Table 29. Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2024-2033)
Table 31. North America Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Patient-derived Xenograft (PDX) Models Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Patient-derived Xenograft (PDX) Models Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Patient-derived Xenograft (PDX) Models Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Patient-derived Xenograft (PDX) Models Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Patient-derived Xenograft (PDX) Models Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Patient-derived Xenograft (PDX) Models Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country (2024-2033) & (US$ Million)
Table 46. Crown Bioscience Company Detail
Table 47. Crown Bioscience Business Overview
Table 48. Crown Bioscience Patient-derived Xenograft (PDX) Models Product
Table 49. Crown Bioscience Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 50. Crown Bioscience Recent Development
Table 51. Champions Oncology Company Detail
Table 52. Champions Oncology Business Overview
Table 53. Champions Oncology Patient-derived Xenograft (PDX) Models Product
Table 54. Champions Oncology Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 55. Champions Oncology Recent Development
Table 56. Wuxi Apptec Company Detail
Table 57. Wuxi Apptec Business Overview
Table 58. Wuxi Apptec Patient-derived Xenograft (PDX) Models Product
Table 59. Wuxi Apptec Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 60. Wuxi Apptec Recent Development
Table 61. The Jackson Laboratory Company Detail
Table 62. The Jackson Laboratory Business Overview
Table 63. The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product
Table 64. The Jackson Laboratory Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 65. The Jackson Laboratory Recent Development
Table 66. EPO Berlin-Buch Company Detail
Table 67. EPO Berlin-Buch Business Overview
Table 68. EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product
Table 69. EPO Berlin-Buch Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 70. EPO Berlin-Buch Recent Development
Table 71. Oncodesign Company Detail
Table 72. Oncodesign Business Overview
Table 73. Oncodesign Patient-derived Xenograft (PDX) Models Product
Table 74. Oncodesign Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 75. Oncodesign Recent Development
Table 76. Xentech Company Detail
Table 77. Xentech Business Overview
Table 78. Xentech Patient-derived Xenograft (PDX) Models Product
Table 79. Xentech Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 80. Xentech Recent Development
Table 81. Envigo Company Detail
Table 82. Envigo Business Overview
Table 83. Envigo Patient-derived Xenograft (PDX) Models Product
Table 84. Envigo Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 85. Envigo Recent Development
Table 86. Charles River Laboratories Company Detail
Table 87. Charles River Laboratories Business Overview
Table 88. Charles River Laboratories Patient-derived Xenograft (PDX) Models Product
Table 89. Charles River Laboratories Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 90. Charles River Laboratories Recent Development
Table 91. Pharmatest Services Company Detail
Table 92. Pharmatest Services Business Overview
Table 93. Pharmatest Services Patient-derived Xenograft (PDX) Models Product
Table 94. Pharmatest Services Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 95. Pharmatest Services Recent Development
Table 96. Urosphere Company Detail
Table 97. Urosphere Business Overview
Table 98. Urosphere Patient-derived Xenograft (PDX) Models Product
Table 99. Urosphere Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 100. Urosphere Recent Development
Table 101. MEDICILON Company Detail
Table 102. MEDICILON Business Overview
Table 103. MEDICILON Patient-derived Xenograft (PDX) Models Product
Table 104. MEDICILON Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 105. MEDICILON Recent Development
Table 106. Horizon Discovery Company Detail
Table 107. Horizon Discovery Business Overview
Table 108. Horizon Discovery Patient-derived Xenograft (PDX) Models Product
Table 109. Horizon Discovery Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 110. Horizon Discovery Recent Development
Table 111. Shanghai Model Organisms Center Company Detail
Table 112. Shanghai Model Organisms Center Business Overview
Table 113. Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product
Table 114. Shanghai Model Organisms Center Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 115. Shanghai Model Organisms Center Recent Development
Table 116. GemPharmatech Company Detail
Table 117. GemPharmatech Business Overview
Table 118. GemPharmatech Patient-derived Xenograft (PDX) Models Product
Table 119. GemPharmatech Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 120. GemPharmatech Recent Development
Table 121. LIDE Biotech Company Detail
Table 122. LIDE Biotech Business Overview
Table 123. LIDE Biotech Patient-derived Xenograft (PDX) Models Product
Table 124. LIDE Biotech Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 125. LIDE Biotech Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Patient-derived Xenograft (PDX) Models Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Patient-derived Xenograft (PDX) Models Market Share by Type: 2022 VS 2033
Figure 3. Mouse Model Features
Figure 4. Rat Model Features
Figure 5. Global Patient-derived Xenograft (PDX) Models Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Patient-derived Xenograft (PDX) Models Market Share by Application: 2022 VS 2033
Figure 7. Preclinical Drug development Case Studies
Figure 8. Biomarker Analysis Case Studies
Figure 9. Patient-derived Xenograft (PDX) Models Report Years Considered
Figure 10. Global Patient-derived Xenograft (PDX) Models Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Patient-derived Xenograft (PDX) Models Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Patient-derived Xenograft (PDX) Models Market Share by Region: 2022 VS 2033
Figure 13. Global Patient-derived Xenograft (PDX) Models Market Share by Players in 2022
Figure 14. Global Top Patient-derived Xenograft (PDX) Models Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patient-derived Xenograft (PDX) Models as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Patient-derived Xenograft (PDX) Models Revenue in 2022
Figure 16. North America Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Patient-derived Xenograft (PDX) Models Market Share by Country (2018-2033)
Figure 18. United States Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Patient-derived Xenograft (PDX) Models Market Share by Country (2018-2033)
Figure 22. Germany Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Share by Region (2018-2033)
Figure 30. China Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Patient-derived Xenograft (PDX) Models Market Share by Country (2018-2033)
Figure 38. Mexico Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Share by Country (2018-2033)
Figure 42. Turkey Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Crown Bioscience Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 45. Champions Oncology Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 46. Wuxi Apptec Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 47. The Jackson Laboratory Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 48. EPO Berlin-Buch Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 49. Oncodesign Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 50. Xentech Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 51. Envigo Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 52. Charles River Laboratories Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 53. Pharmatest Services Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 54. Urosphere Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 55. MEDICILON Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 56. Horizon Discovery Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 57. Shanghai Model Organisms Center Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 58. GemPharmatech Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 59. LIDE Biotech Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed